Pages that link to "Q28345957"

The following pages link to Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase (Q28345957):

Displayed 24 items.

• Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif (Q24304030) ‎ (← links)
• LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration (Q24671948) ‎ (← links)
• Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo Acids (Q26800036) ‎ (← links)
• Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells (Q31036545) ‎ (← links)
• Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA. (Q33849497) ‎ (← links)
• Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load (Q34348055) ‎ (← links)
• Reduced Monomeric CD4 Is the Preferred Receptor for HIV (Q34412686) ‎ (← links)
• In search of authentic inhibitors of HIV-1 integration (Q34785977) ‎ (← links)
• Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds (Q35091567) ‎ (← links)
• Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection (Q36744775) ‎ (← links)
• Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells (Q37039142) ‎ (← links)
• Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo (Q37256641) ‎ (← links)
• Transduction of terminally differentiated neurons by avian sarcoma virus (Q37423151) ‎ (← links)
• Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity (Q37857291) ‎ (← links)
• Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients (Q38391209) ‎ (← links)
• Vif-deficient HIV reverse transcription complexes (RTCs) are subject to structural changes and mutation of RTC-associated reverse transcription products (Q40288993) ‎ (← links)
• Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system (Q40624947) ‎ (← links)
• Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors (Q40663130) ‎ (← links)
• Evaluation of PCR-based methods for the quantitation of integrated HIV-1 DNA. (Q40702005) ‎ (← links)
• Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro (Q41148526) ‎ (← links)
• Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integr (Q42798789) ‎ (← links)
• Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. (Q44044931) ‎ (← links)
• Novel pathway of human immunodeficiency virus type 1 uptake and release in astrocytes (Q45420314) ‎ (← links)
• Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication. (Q52619009) ‎ (← links)